Nextosmet 15/850 mg Tablets
Metformin Hydrochloride · Pioglitazone Hydrochloride
Prescription medication · Combination
Nexpam Korea Co., Ltd.
MFDS item code 201801325 · Approved 2018.03.27
This product's status changed to Expired on 2023.03.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used as an adjunct when implementing dietary management and exercise therapy to help control blood sugar levels in patients with non-insulin-dependent diabetes, that is, type 2 diabetes. It is particularly administered when blood sugar control is inadequate with metformin or pioglitazone alone, or when it is desired to replace treatment with both medications. Management of type 2 diabetes is very important and should include nutritional counseling, weight loss if necessary, and consistent exercise, with these lifestyle modifications enhancing the effectiveness of drug therapy. This medication is used in conjunction with such comprehensive treatment strategies to help improve blood sugar control.
For the treatment of patients with type 2 diabetes mellitus, the dose of this drug should be individualized based on efficacy and tolerability, without exceeding the maximum dose of each component: pioglitazone 30mg and metformin 2500mg. The initial dose of this drug should be based on the patient's current treatment regimen. 1. Patients whose blood glucose is not adequately controlled with metformin or pioglitazone monotherapy: The dose should be based on the current dose of metformin or pioglitazone. Start with 1 tablet of this drug daily and gradually adjust the dose after assessing the adequacy of the therapeutic response. 2. Patients switching from combination therapy with pioglitazone and metformin: Patients switching from combination therapy with pioglitazone and metformin to this drug may start at the doses of pioglitazone and metformin they were previously receiving. Studies have not been conducted to assess the safety and efficacy of switching from other oral antihyperglycemic agents to this drug. Any change in the treatment regimen for type 2 diabetes may alter glycemic control; therefore, caution should be exercised and appropriate monitoring should be performed. 3. Patients with renal impairment: All dose adjustments should be based on a careful assessment of renal function. In general, elderly, debilitated, and malnourished patients should not be titrated up to the maximum dose of this drug. After administration of this drug to a patient, or after an increase in dose, the patient must be carefully monitored for adverse reactions associated with fluid retention. This drug should generally be administered in divided doses with meals, which may reduce gastrointestinal adverse reactions caused by metformin. Sufficient time is needed to assess the adequacy of the therapeutic response. Ideally, response to treatment should be assessed using glycated hemoglobin (HbA1C), which is a better indicator of long-term glycemic control than fasting plasma glucose (FPG). HbA1c reflects blood glucose levels over the previous 2 - 3 months. In clinical use of this drug, if glycemic control measured by FPG does not worsen, administration for an appropriate period (8-12 weeks) is recommended to assess changes in HbA1C.
This medication is used to treat diabetes and helps control blood sugar. However, it may cause a rare side effect known as severe lactic acidosis, which requires caution. Lactic acidosis is a serious condition caused by excessive accumulation of lactic acid in the body, with symptoms including malaise, muscle pain, difficulty breathing, and abdominal pain. If such symptoms occur, immediately inform a physician and discontinue use of this medication. Additionally, this medication may be risky for patients with impaired kidney or liver function, therefore kidney and liver function tests must be conducted prior to use. Especially, patients with reduced kidney function or severe heart failure should not take this medication. During the course of taking this medication, excessive alcohol consumption should be avoided, and use may be temporarily discontinued in cases of dehydration, serious infection, or around the time of surgery. Furthermore, this medication may cause weight gain, edema, or worsening of heart failure in some patients, so patients should consult their doctor if these symptoms arise. Pregnant or breastfeeding women and children are not recommended to use this medication. While taking this medication, it is essential to regularly check health status through blood sugar, kidney function, liver function, and blood tests, as vitamin B12 deficiency may occur and periodic testing is required. Finally, this medication can interact with other drugs, so any other medications being taken must be reported to a physician or pharmacist. Caution is especially needed when taken with heart medications, diuretics, or antibiotics.
Lactic acidosis, hypoglycemia, fatigue, myalgia, dyspnea, asthenia, abdominal pain, hypothermia, hypotension, resistant bradyarrhythmia, upper respiratory infection, diarrhea, complex edema, peripheral edema, headache, nausea, urinary tract infection, sinusitis, dizziness, lower extremity edema, weight gain, myalgia, dental disorders, worsening of diabetes, pharyngitis, anemia, abnormal liver function tests, elevated serum creatine phosphokinase, vision reduction, diabetic macular edema, liver failure, congestive heart failure, fluid retention, edema, fracture, abnormal blood glucose, gastroenteritis, dyspepsia, insomnia, dry mouth, constipation, abdominal distension, gastroesophageal reflux disease, intraluminal gas in the gastrointestinal tract, increased blood creatinine, increased blood urea, failure of blood glucose control, hypoglycemia, gross hematuria, urination disorders, urgency
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a sealed container. Also, to ensure safe use, it is important to store it at room temperature, specifically between 1℃ and 30℃.
White to grayish-white oblong film-coated tablet
30 tablets (10 tablets/PTP x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Metformin Hydrochloride · Pioglitazone Hydrochloride
Prescription medication · Combination
Nexpam Korea Co., Ltd.
Pioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Dalim Biotech Co., Ltd.
CombinationPioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
CombinationPioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Ilhwa Co., Ltd.
CombinationPioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Medica Korea Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.